510(k) device
Quantra QPlus System
Hemosonics, LLC · Coagulation System For The Measurement Of Whole Blood Viscoelastic Properties (QFR, Class II) · First FDA decision Aug 21, 2020, newest Dec 13, 2022Anemia, clotting and blood disordersSurgical bleeding and hemostasis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
2
Naming "Quantra QPlus"
MAUDE reports
0
Brand "Quantra QPlus", since 2015
PubMed studies
17
Mentioning "Quantra QPlus"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Quantra QPlus System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Quantra QPlus System510(k)
K223433 · Decided Dec 13, 2022 · 29 days after receipt
Device type: Coagulation System For The Measurement Of Whole Blood Viscoelastic Properties (QFR) · Laboratory Medicine & Pathology
- Quantra QPlus System510(k)
K201513 · Decided Aug 21, 2020 · 74 days after receipt
Device type: Coagulation System For The Measurement Of Whole Blood Viscoelastic Properties (QFR) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Quantra QPlus", any status and sponsor, newest update first.
- Quantra Point-of-Care Hemostasis MonitoringPivotal-lookingActive, not recruiting
The Cleveland ClinicAcademic, hospital or other
NCT06328647 · 666 participants (planned) · Start Oct 3, 2024 · Primary completion Dec 31, 2026
Device: POC Quantra QPlus System · For: Bleeding; Hemostatic Disorder
Sites: Cleveland, Ohio
- QPlus Pediatric Reference IntervalTerminated
HemoSonics LLCNot on our public-company list
NCT05645133 · 93 participants · Start Feb 27, 2023 · Primary completion Jun 1, 2023
Device: Diagnostic Test · For: Pediatric ALL; Healthy
Sites: Miami, Florida
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Quantra QPlus", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QFR
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Quantra QPlus"[tiab]. The summary above synthesizes these.
- Multicenter Evaluation of the Quantra QPlus System in Adult Patients Undergoing Major Surgical Procedures.
Groves DS, Welsby IJ, Naik BI, et al. · Anesth Analg · 2020Multicenter Study, Observational Study
- Comparison of the Quantra QPlus System With Thromboelastography in Cardiac Surgery.
DeAnda A, Levy G, Kinsky M, et al. · J Cardiothorac Vasc Anesth · 2021Observational Study
- Comparison of the Quantra QPlus and ROTEM Goal-Directed Transfusion Protocols in Cardiothoracic Surgery Patients: A Prospective Observational Study.
Willers V, Krumeich JRL, Hulshof AM, et al. · J Cardiothorac Vasc Anesth · 2024Observational Study, Comparative Study
- Efficacy of Quantra-Qplus System for Rapid Diagnosis and Treatment of Hypofibrinogenemia and Thrombocytopenia After Cardiopulmonary Bypass.
Suzuki H, Ogawa H, Endo S, et al. · J Cardiothorac Vasc Anesth · 2025Observational Study, Research Support, Non-U.S. Gov't
- Unique Approach to Quality Assurance in Viscoelastic Testing.
Leadbetter NH, Givens TB, Viola F · J Appl Lab Med · 2020
- Sonorheometry Quantra QPlus Characteristics in Adult Cardiac Surgical Patients: An Observational Cohort Study.
Knio ZO, Marche CA, Khan J, et al. · Anesth Analg · 2026
- Comparison of the Quantra® QPlus sonorheometry with conventional hemostasis laboratory and TEG-5000® parameters.
Frédéric S, Istaces N, Lovqvist L, et al. · Perfusion · 2026Evaluation Study
- Retrospective study assessing outcomes in cardiac surgery after implementation of Quantra.
Tibi P, Thompson J, Attaran S, et al. · J Cardiothorac Surg · 2023
- Baseline values for Quantra® QPlus® in healthy pregnant women at term and comparison to standard laboratory coagulation values: a prospective observational study.
Anakmeteeprugsa S, Gonzalez-Fiol A, Garay A, et al. · BMC Pregnancy Childbirth · 2025Observational Study, Comparative Study
- Prediction of hypofibrinogenemia and thrombocytopenia at the point of care with the Quantra® QPlus® System.
Naik BI, Tanaka K, Sudhagoni RG, et al. · Thromb Res · 2021Multicenter Study, Observational Study
- Comparison of the resonance sonorheometry based Quantra® system with rotational thromboelastometry ROTEM® sigma in cardiac surgery - a prospective observational study.
Baulig W, Akbas S, Schütt PK, et al. · BMC Anesthesiol · 2021Comparative Study, Observational Study
- Comparison of the Point-Of-Care Coagulation Device Quantra With the TEG-5000 for Congenital Cardiac Surgery-A Pilot Study.
Ochocinski D, Navaratnam M, Babb A, et al. · Paediatr Anaesth · 2025Observational Study, Comparative Study
Other devices of this type
Also filed under product code QFR.
- Quantra Hemostasis AnalyzerHemosonics, LLC · De Novo 2023
- QStat CartridgeHemosonics, LLC · 510(k) 2024
- Quantra QStat CartridgeHemosonics, LLC · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.